Commodore Capital LP raised its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 47.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 790,000 shares of the company’s stock after purchasing an additional 252,924 shares during the quarter. Akero Therapeutics accounts […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) CFO William Richard White sold 20,777 shares of the firm’s stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $55.00, for a total transaction of $1,142,735.00. Following the sale, the chief financial officer now owns 19,100 shares in the company, […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) CFO William Richard White sold 606 shares of the business’s stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $55.16, for a total value of $33,426.96. Following the transaction, the chief financial officer now owns 22,377 shares of […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) CFO William Richard White sold 606 shares of the stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $55.16, for a total transaction of $33,426.96. Following the transaction, the chief financial officer now owns 22,377 shares of the company’s stock, […]
Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Rating)’s stock price gapped up prior to trading on Monday . The stock had previously closed at $29.85, but opened at $31.30. Ventyx Biosciences shares last traded at $31.78, with a volume of 440,074 shares trading hands. Wall Street Analysts Forecast Growth Several brokerages have issued reports on VTYX. […]